Quoin Pharmaceuticals Ltd... (QNRX)
0.30
0.09 (41.78%)
At close: Apr 02, 2025, 3:59 PM
Quoin Pharmaceuticals Ltd. Income Statement
Financials in USD. Fiscal year
is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | -280K | n/a | -280K | n/a |
| Cost of Revenue | n/a | 103.44K | 103.64K | 104.11K | 104.77K | 227.06K | 125.72K | 104.22K | 89.13K | 18.27K |
| Gross Profit | n/a | -103.44K | -103.64K | -104.11K | -104.77K | -227.06K | -405.72K | -104.22K | -369.13K | -18.27K |
| Operating Income | n/a | -9.38M | -8.85M | -20.37M | -2.05M | -1.56M | 15.32M | 10.17M | 15.32M | -2.6M |
| Interest Income | n/a | 692.82K | 95.75K | 1.37K | 47.02 | n/a | n/a | n/a | n/a | 1.03K |
| Pretax Income | -8.96B | -8.66M | -9.38M | -21.46M | -2.1M | -1.56M | 15.32M | 10.17M | 15.32M | -2.62M |
| Net Income | -8.96B | -8.69M | -9.28M | -8.52M | -1.76M | -1.56M | 15.32M | 10.17M | 15.32M | -2.62M |
| Selling & General & Admin | 5.93B | 6.07M | 6.58M | 4.5M | 1.43M | 1.51M | 7.97M | 4.2M | 7.97M | 1.06M |
| Research & Development | 3.6B | 3.31M | 2.67M | 1.56M | 244.16K | 45.65K | 8.26M | 5.89M | 8.26M | 1.52M |
| Other Expenses | n/a | n/a | 417.31K | -14.03M | -378.33K | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 9.53B | 9.38M | 9.26M | 6.06M | 1.67M | 1.56M | 16.22M | 10.1M | 16.22M | 2.58M |
| Interest Expense | n/a | n/a | 714.08K | 1.09M | 47.02K | 412.29K | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | n/a | 9.38M | 9.26M | 6.06M | 1.67M | 1.56M | 16.22M | 10.1M | 16.22M | 2.6M |
| Income Tax | n/a | 22.38K | -104.04K | -12.94M | -331.31K | 1.55M | -161.14K | -1.17M | 147.94K | -1 |
| Shares Outstanding (Basic) | 4.69M | 900.92K | 403.88K | 26.41K | 20.02K | 3.54K | 2.16K | 1.87K | 1.52K | 1.24K |
| Shares Outstanding (Diluted) | 4.69M | 901.1K | 403.88K | 26.41K | 20.02K | 3.54K | 2.16K | 1.87K | 1.52K | 1.24K |
| EPS (Basic) | -1.91K | -9.64 | -22.97 | -322.49 | -88.1 | -440.29 | 7.1K | 5.45K | 10.08K | -2.11K |
| EPS (Diluted) | -1.91K | -9.64 | -22.97 | -322.49 | -88.1 | -440.29 | 7.1K | 5.45K | 10.08K | -2.11K |
| EBITDA | n/a | -9.27M | -8.74M | -21.37M | -2.01M | -1.54M | -5.47M | -7.8M | -3.91M | -2.6M |
| EBIT | n/a | -9.38M | -8.63M | -21.48M | -2.11M | -4.31M | -5.59M | -7.91M | -3.99M | -2.62M |
| Depreciation & Amortization | n/a | 103.44K | 103.64K | 104.11K | 104.77K | 227.06K | 125.72K | 104.22K | 89.13K | 18.27K |